ResMed Inc.
RMD
$277.05
$3.241.18%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 1.40B | 1.31B | 1.25B | 1.11B | 1.02B |
Total Depreciation and Amortization | 210.34M | 190.39M | 192.62M | 189.56M | 188.76M |
Total Amortization of Deferred Charges | 25.47M | 25.89M | 26.39M | 26.92M | 27.45M |
Total Other Non-Cash Items | 98.32M | 108.30M | 84.95M | 116.18M | 119.32M |
Change in Net Operating Assets | 16.74M | 15.11M | -76.36M | -5.03M | 44.78M |
Cash from Operations | 1.75B | 1.65B | 1.48B | 1.44B | 1.40B |
Capital Expenditure | -89.87M | -84.16M | -84.56M | -87.27M | -99.46M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -139.25M | -20.37M | -23.45M | -30.28M | -133.46M |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 29.07M | -8.31M | -6.21M | -1.11M | -36.86M |
Cash from Investing | -200.05M | -112.84M | -114.21M | -118.66M | -269.78M |
Total Debt Issued | -- | 0.00 | 0.00 | 0.00 | 105.00M |
Total Debt Repaid | -40.00M | -335.00M | -555.00M | -680.00M | -835.00M |
Issuance of Common Stock | 74.44M | 71.98M | 67.85M | 60.49M | 53.09M |
Repurchase of Common Stock | -318.10M | -267.93M | -242.85M | -208.94M | -158.77M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -310.88M | -303.84M | -296.63M | -289.61M | -282.32M |
Other Financing Activities | -11.71M | -855.00K | -855.00K | -855.00K | -1.29M |
Cash from Financing | -606.25M | -835.65M | -1.03B | -1.12B | -1.12B |
Foreign Exchange rate Adjustments | 25.80M | -9.65M | -22.91M | 14.32M | -1.72M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 971.09M | 694.80M | 311.70M | 217.26M | 10.47M |